RUBINSTEIN JULIE

CIK 00017806641 companySEATTLE, WA

SEC Profile

Transactions

Companies

Filings

CIK

0001780664

Recent Transactions

50 trades

Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.99/sh−19,461→ 588,249 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-05$6.98/sh−40,044→ 607,710 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2025-03-04+175,000→ 647,754 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.56/sh−13,490→ 472,754 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-05$3.43/sh−25,580→ 486,244 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2024-03-04+175,000→ 511,824 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06+132,979→ 359,492 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2023-03-06$8.57/sh−22,668→ 336,824 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (right to buy)
2023-03-06+199,549→ 199,549 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-07$12.01/sh−4,613→ 226,513 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2022-03-04+185,338→ 231,126 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2022-03-04+463,344→ 463,344 total
Award
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-04+45,788→ 45,788 total
Award
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-04+114,469→ 114,469 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$58.99/sh−845→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-03-01−15,000→ 225,325 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$6.55/sh+15,000→ 15,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$57.54/sh−4,684→ 10,316 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-03-01$58.64/sh−9,471→ 845 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-26$6.55/sh+15,000→ 15,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-26$56.23/sh−15,000→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-02-26−15,000→ 240,325 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-25$56.13/sh−14,076→ 599 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-25$57.33/sh−599→ 0 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-02-25−14,675→ 255,325 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-25$6.55/sh+14,675→ 14,675 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-24$57.12/sh−4,134→ 6,632 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-24$58.74/sh−3,374→ 3,258 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-24$6.55/sh+15,000→ 15,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-24$59.33/sh−3,258→ 0 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-24$56.45/sh−4,234→ 10,766 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-02-24−15,000→ 270,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-02-23−15,000→ 255,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-23$55.54/sh−4,461→ 7,039 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-23$6.55/sh+15,000→ 15,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-23$54.16/sh−3,500→ 11,500 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-23$56.04/sh−7,039→ 0 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-22$59.28/sh−9,844→ 5,156 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-22$61.01/sh−400→ 656 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-02-22−15,000→ 270,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-22$6.55/sh+15,000→ 15,000 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-22$60.21/sh−4,100→ 1,056 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-22$62.20/sh−656→ 0 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-19$63.03/sh−3,793→ 0 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-19$62.30/sh−7,708→ 3,793 total
Sale
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-19$61.47/sh−3,499→ 11,501 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-19$6.55/sh+15,000→ 15,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-02-19−15,000→ 285,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Common Stock
2021-02-18$6.55/sh+15,000→ 15,000 total
Exercise/Conversion
Adaptive Biotechnologies Corp$ADPT
Stock Option (Right to Buy)
2021-02-18−15,000→ 300,000 total

Companies

Adaptive Biotechnologies Corp
President and COO
$ADPT

Recent Filings

Address

C/O ADAPTIVE BIOTECHNOLOGIES CORPORATION 1165 EASTLAKE AVENUE EAST

SEATTLE, WA, 98109

View on SEC.gov